Molecular Partners AG (MOLN)
NASDAQ: MOLN
· Real-Time Price · USD
3.45
-0.07 (-1.99%)
At close: Aug 15, 2025, 3:43 PM
3.53
2.27%
After-hours: Aug 15, 2025, 04:04 PM EDT
Molecular Partners Cash Flow Statement
Financials in CHF. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -16.77M | -11.23M | -16.4M | -15.08M | -11.32M | -19.78M | -11.44M | -15.99M | -14.78M | -17.43M | -13.32M | -4.52M | 153.13M | -17.91M | -12.31M | -17.01M | -16.55M |
Depreciation & Amortization | 552K | 570K | 591K | 603K | 605K | 602K | 604K | 604K | 610K | 599K | 584K | 582K | 623K | 626K | 623K | 656K | 660K |
Stock-Based Compensation | 1.14M | 1.06M | 1.06M | 1.13M | 854K | 1.15M | 1M | 1.31M | 1.75M | 1.14M | 1.08M | 1.52M | 1.35M | 1.23M | 1M | 1.06M | 789K |
Other Working Capital | -1.83M | 138K | -558K | -1.11M | -3.46M | -259K | -1.37M | 576K | -3.99M | -1.23M | -5.18M | -8.52M | 8.92M | -5.53M | -7.95M | -8.27M | -12.92M |
Other Non-Cash Items | 779K | -4.73M | 1.98M | 3.3M | -1.72M | 7.7M | -2.05M | 98K | -129K | 2.65M | -1.31M | -1.64M | -455K | 2.24M | -529K | 748K | -1.98M |
Deferred Income Tax | -2K | n/a | n/a | n/a | n/a | -3.31M | 65K | 115K | n/a | n/a | n/a | n/a | n/a | 2K | 80K | 163K | 120K |
Change in Working Capital | -2.78M | 1.14M | -509K | -1.63M | -2.8M | -1.22M | -1.37M | 576K | -3.99M | -1.23M | -5.18M | -8.52M | 8.92M | -5.53M | -7.95M | -8.27M | -12.92M |
Operating Cash Flow | -17.08M | -13.2M | -13.28M | -14.52M | -15.79M | -14.87M | -13.19M | -13.28M | -16.54M | -14.27M | -18.15M | -12.58M | 163.56M | -19.33M | -19.09M | -22.65M | -29.88M |
Capital Expenditures | -448K | -137K | -258K | -197K | -131K | -310K | -156K | -182K | -160K | -629K | -252K | -156K | -380K | -389K | -418K | -340K | -160K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | -19.76M | 64K | 62K | n/a | n/a | n/a | n/a | n/a | -138K | -52K | -115K | -69K |
Purchase of Investments | -19.13M | -59.8M | -60.47M | -57.59M | -62.19M | -49.51M | -72.83M | -70.65M | -84.82M | -32.56M | -115.72M | -25.33M | -125.8M | -8.24M | -52.94M | -18.27M | -9.43M |
Sales Maturities Of Investments | 54.13M | 54.52M | 74.09M | 69.73M | 78.67M | 68.16M | 89.56M | 74.14M | 87.58M | 68.8M | 88.42M | 9.44M | 32.57M | 18.58M | 29.29M | 10M | 10M |
Other Investing Acitivies | 411K | 918K | 859K | 13.34M | 17.73M | 19.76M | 1.14M | 666K | 774K | 298K | 139K | 8K | 49K | 173K | 78K | 120K | 73K |
Investing Cash Flow | 34.96M | -4.49M | 14.22M | 11.95M | 16.35M | 18.34M | 17.77M | 4.04M | 3.37M | 35.9M | -27.42M | -16.04M | -93.56M | 9.99M | -24.04M | -8.6M | 412K |
Debt Repayment | -303K | -303K | -302K | -302K | -301K | -300K | -300K | -299K | -299K | -298K | -298K | -297K | -296K | -295K | -295K | -295K | -294K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3K | -628K | n/a | n/a | n/a | -911K | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1K | 15.6M | 1K | 35K | 1K | 2K | 2K | 25K | 2K | 3K | 3K | 18K | 226K | 70K | 69K | 52.55M | 50K |
Financial Cash Flow | -302K | 15.3M | -301K | -267K | -300K | -298K | -298K | -274K | -297K | -298K | -923K | -279K | -70K | -225K | -1.21M | 52.26M | -244K |
Net Cash Flow | 17.5M | -1.88M | 66K | -15.01M | -12.76M | -19.73M | 5.16M | -10.69M | -14.02M | 18.24M | -45.24M | -27.08M | 70.21M | -11.09M | -43.66M | 20.39M | -27.55M |
Free Cash Flow | -17.53M | -13.33M | -13.54M | -14.72M | -15.92M | -15.18M | -13.35M | -13.46M | -16.7M | -14.89M | -18.41M | -12.73M | 163.18M | -19.72M | -19.5M | -22.99M | -30.04M |